These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 10797598)
1. Pharmacogenomics: the genomics of drug response. March R Yeast; 2000 Apr; 17(1):16-21. PubMed ID: 10797598 [TBL] [Abstract][Full Text] [Related]
2. [Pharmacogenomics: the quest for individualized therapy]. López-López M; Guerrero-Camacho JL; Familiar-López IM; Jung-Cook H; Corona-Vázquez T; Alonso-Vilatela ME Rev Neurol; 2004 Dec 1-15; 39(11):1063-71. PubMed ID: 15597270 [TBL] [Abstract][Full Text] [Related]
3. Human genome project: pharmacogenomics and drug development. Ganguly NK; Bano R; Seth SD Indian J Exp Biol; 2001 Oct; 39(10):955-61. PubMed ID: 11883519 [TBL] [Abstract][Full Text] [Related]
4. Human genetic variation and personalized medicine. Agrawal S; Khan F Indian J Physiol Pharmacol; 2007; 51(1):7-28. PubMed ID: 17877289 [TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics and the concept of individualized medicine. Shastry BS Pharmacogenomics J; 2006; 6(1):16-21. PubMed ID: 16302022 [TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics/genomics and personalized medicine. Sadée W; Dai Z Hum Mol Genet; 2005 Oct; 14 Spec No. 2():R207-14. PubMed ID: 16244319 [TBL] [Abstract][Full Text] [Related]
7. Can personalized drug therapy be achieved? A closer look at pharmaco-metabonomics. Nebert DW; Vesell ES Trends Pharmacol Sci; 2006 Nov; 27(11):580-6. PubMed ID: 17005258 [TBL] [Abstract][Full Text] [Related]
8. DMET microarray technology for pharmacogenomics-based personalized medicine. Burmester JK; Sedova M; Shapero MH; Mansfield E Methods Mol Biol; 2010; 632():99-124. PubMed ID: 20217574 [TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomics: historical perspective and current status. Kalow W Methods Mol Biol; 2005; 311():3-15. PubMed ID: 16100395 [TBL] [Abstract][Full Text] [Related]
10. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
12. Progress in pharmacogenomics and its promise for medicine. Blake CA; Sobel BE Exp Biol Med (Maywood); 2008 Dec; 233(12):1482-3. PubMed ID: 18849537 [TBL] [Abstract][Full Text] [Related]
13. Translation towards personalized medicine in Multiple Sclerosis. Miller A; Avidan N; Tzunz-Henig N; Glass-Marmor L; Lejbkowicz I; Pinter RY; Paperna T J Neurol Sci; 2008 Nov; 274(1-2):68-75. PubMed ID: 18789804 [TBL] [Abstract][Full Text] [Related]
14. [Pharmacogenomics genomics approaches to optimizing drug therapy]. Shi J; Chen S Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Apr; 19(2):156-8. PubMed ID: 11941596 [TBL] [Abstract][Full Text] [Related]
15. Evolution of pharmacogenomics. Somogy A Proc West Pharmacol Soc; 2008; 51():1-4. PubMed ID: 19544663 [TBL] [Abstract][Full Text] [Related]
18. Ontogeny and drug metabolism in newborns. Dotta A; Chukhlantseva N J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 4():83-4. PubMed ID: 22958028 [TBL] [Abstract][Full Text] [Related]
19. Recent development in pharmacogenomics: from candidate genes to genome-wide association studies. Grant SF; Hakonarson H Expert Rev Mol Diagn; 2007 Jul; 7(4):371-93. PubMed ID: 17620046 [TBL] [Abstract][Full Text] [Related]
20. Pharmacogenomics - therapeutic and ethical issues. Patowary S Kathmandu Univ Med J (KUMJ); 2005; 3(4):428-30. PubMed ID: 16449851 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]